Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry ; volume:11 ; number:2 ; day:18 ; month:2 ; year:2022 ; pages:797-810 ; date:4.2022
Ophthalmology and therapy ; 11, Heft 2 (18.2.2022), 797-810, 4.2022
- Urheber
-
Bhandari, Sanjeeb
Gabrielle, Pierre-Henry
Nguyen, Vuong
Daien, Vincent
Viola, Francesco
Bougamha, Walid
Young, Stephanie
Romero-Nuñez, Barbara
Figueras-Roca, Marc
Zarranz-Ventura, Javier
Barthelmes, Daniel
Sararols, Laura
Gillies, Mark
Creuzot-Garcher, Catherine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-022-00473-3
- URN
-
urn:nbn:de:101:1-2022060821145149950087
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bhandari, Sanjeeb
- Gabrielle, Pierre-Henry
- Nguyen, Vuong
- Daien, Vincent
- Viola, Francesco
- Bougamha, Walid
- Young, Stephanie
- Romero-Nuñez, Barbara
- Figueras-Roca, Marc
- Zarranz-Ventura, Javier
- Barthelmes, Daniel
- Sararols, Laura
- Gillies, Mark
- Creuzot-Garcher, Catherine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Influence of macular oedema on the measurement of macular pigment optical density
Bilateral blindness after uneventful brolucizumab injection for macular degeneration
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Cystoid macular oedema associated with Rosai–Dorfman disease: a case report
Oedema.
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Influence of macular oedema on the measurement of macular pigment optical density
Bilateral blindness after uneventful brolucizumab injection for macular degeneration
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Cystoid macular oedema associated with Rosai–Dorfman disease: a case report
Oedema.
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Influence of macular oedema on the measurement of macular pigment optical density
Bilateral blindness after uneventful brolucizumab injection for macular degeneration
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Cystoid macular oedema associated with Rosai–Dorfman disease: a case report
Oedema.